Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?

Clin Auton Res. 2017 Jul;27(Suppl 1):1-3. doi: 10.1007/s10286-017-0426-6. Epub 2017 Jun 16.

Author

Horacio Kaufmann¹

Affiliation

¹ Department of Neurology, Dysautonomia Center, New York University School of Medicine, 530 First Avenue, Suite 9Q, New York, NY, 10017, USA. Horacio.Kaufmann@nyumc.org.

PMID: 28623419
DOI: 10.1007/s10286-017-0426-6

No abstract available

Publication types

Editorial
Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Antiparkinson Agents / therapeutic use*
Clinical Trials as Topic
Droxidopa / therapeutic use*
Humans
Hypotension, Orthostatic / drug therapy*

Substances

Antiparkinson Agents
Droxidopa